Clinical Trials on FLT3-Mutated High-Risk Myelodysplastic Syndrome in Sweden
Total 2 results
-
Novartis PharmaceuticalsCompletedLow and Int 1-risk Myelodysplastic SyndromeGermany, Canada, Korea, Republic of, Sweden, Spain, China, Argentina, Italy, United Kingdom, Algeria
-
CellCentric Ltd.RecruitingAcute Myeloid Leukemia | Multiple Myeloma | Non Hodgkin Lymphoma | Peripheral T Cell Lymphoma | Haematological Malignancy | Higher-risk Myelodysplastic SyndromeUnited Kingdom, United States, France, Sweden, Spain